EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Current Options in the Treatment of Mast Cell Mediator-Related Symptoms in Mastocytosis

Luis Escribano, Cem Akin, Mariana Castells, Lawrence B Schwartz

Inflammation & Allergy-Drug Targets · 2006

DOI: 10.2174/187152806775269303 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Inflammation & Allergy-Drug Targets, 2006. Verfasst von Luis Escribano und 3 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Mastocitosis, Laboratorio K.Frank Austen, Hospital Ramón y Cajal, Red Española de Mastocitosis, Madrid, Spain. lescribano.hrc@salud.madrid.…. Die Arbeit wurde bisher 76-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with mastocytosis have symptoms related to the tissue response to the release of mediators from mast cells (MC), local mast cell burden or associated non-mast cell hematological disorders. MC contain an array of biologically active mediators in their granules, which are preformed and stored. MC are also able to produce newly generated membrane-derived lipid mediators and are a source of multifunctional cytokines. Mediator-related symptoms can include pruritus, flushing, syncope, gastric distress, nausea and vomiting, diarrhea, bone pain and neuropsychiatric disturbances; these symptoms are variably controlled by adequate medications. Management of patients within all categories of mastocytosis includes: a) a careful counseling of patients (parents in pediatric cases) and care providers, b) avoidance of factors triggering acute mediator release, c) treatment of acute and chronic MC-mediator symptoms and, if indicated, d) an attempt for cytoreduction and treatment of organ infiltration by mast cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsChymasesHistamine AntagonistsHumansInflammation MediatorsMast CellsMastocytosisSerine EndopeptidasesTryptases

Substanzen

Histamine AntagonistsInflammation MediatorsSerine EndopeptidasesChymasesTryptases

Autor:innen und Institutionen

  • Unidad de Mastocitosis, Laboratorio K.Frank Austen, Hospital Ramón y Cajal, Red Española de Mastocitosis, Madrid, Spain. lescribano.hrc@salud.madrid.org

Zitieren

APA

Escribano, L., Akin, C., Castells, M., & Schwartz, L. B. (2006). Current Options in the Treatment of Mast Cell Mediator-Related Symptoms in Mastocytosis. Inflammation & Allergy-Drug Targets. https://doi.org/10.2174/187152806775269303

Vancouver

Escribano L, Akin C, Castells M, Schwartz LB. Current Options in the Treatment of Mast Cell Mediator-Related Symptoms in Mastocytosis. Inflammation & Allergy-Drug Targets. 2006. doi:10.2174/187152806775269303

BibTeX
@article{Escribano2006,
  author = {Escribano, Luis and Akin, Cem and Castells, Mariana and Schwartz, Lawrence B},
  title = {Current Options in the Treatment of Mast Cell Mediator-Related Symptoms in Mastocytosis},
  journal = {Inflammation & Allergy-Drug Targets},
  year = {2006},
  doi = {10.2174/187152806775269303}
}
Kostenlos starten →